ALMIRALL, S.A.
Headquarters address: Via Agusta 187
CIF A58869389 Spain Chemical industry Pharmaceutical seen 1323 times Last report December 2020
Employees | 592 (57.10% women) |
Profit | 116.7M € |
Indebtedness | 75.84% |
Income | 1,233M € |
Earnings per share | 0.66 € |
Solvency | 231.9% | -0.5% |
Short solvency | 75.78% | -39.62% |
Working balance on income | 1.23% | -91.44% |
Working balance on assets | 3.1% | -92.9% |
Non current assets coverage | 72.33% | 3.7% |
Fixed assets on long term debt | 253.7% | 45.3% |
Cash on Current Assets | 32.6% | 43.54% |
Inmovilization | 78.62% | -3.93% |
Cash on Current Liabilities | 33.64% | -16.62% |
Leverage | 20.9% | -1.06% |
Debt Quality | 51.97% | -31.77% |
Financial Expenses Coverage | 557.7% | -36.41% |
Short term Indebtedness | 36.42% | 103.4% |
Long term Indebtedness | 39.42% | -31.18% |
Financial Expenses on EBIT | 17.93% | 57.26% |
Indebtedness Ratio | 43.13% | 0.5% |
Indebtedness on EBIT | 661% | 37.36% |
Assets Turnover | 53.84% | -2.43% |
Customers Turnover | -1.11K% | 13.18% |
Fixed Assets Turnover | 68.47% | 1.56% |
Suppliers Turnover | 168.5% | 0.79% |
Profit on Income/Sales | 9.46% | -18.27% |
Earnings per share | 0.66 € | -22.35% |
Funds from Operations | 301.7M € | -11.18% |
EBIT Margin | 12.12% | -25.02% |
Operating Margin | 10.51% | -24.62% |
ROA | 5.09% | -20.26% |
ROE | 8.95% | -19.96% |
Profitability | 5.44% | -26.44% |
Economic Profitability | 6.53% | -26.84% |
Rea Estate Profitability | -197.9% | 38.16% |
Expenses/Profit | 179.1% | 36.23% |
EBIT | -557.7% | -36.41% |
Staff expenses | 452.1K € | -1.67% |
Financial Expenses on Sales | 2.17% | 17.92% |
Cash Flow per share | 273.7K | 84.57% |
Cash Flow on assets | 2.11% | 89.55% |
Cash Flow on income/sales | 3.92% | 94.27% |
Dividends on Cash Flow | 0% | 0% |
Cash Flow Margin Ratio | 13.36% | -27.58% |
Cash Flow on short-term Liabilities | -10.19% | -6.45% |
Cash Flow on long-term Liabilities | -9.42% | 176.4% |
Cash Flow on Debt | -10.1% | 91.58% |
External Financing | -84.48% | -66.85% |